- Home
- JAGX vs AMZE Comparison
JAGX vs AMZE Comparison
Compare JAGX & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- AMZE
- Stock Information
- Founded
- JAGX 2013
- AMZE 2019
- Country
- JAGX United States
- AMZE United States
- Employees
- JAGX N/A
- AMZE N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- JAGX Health Care
- AMZE Consumer Staples
- Exchange
- JAGX Nasdaq
- AMZE Nasdaq
- Market Cap
- JAGX 7.4M
- AMZE 6.6M
- IPO Year
- JAGX N/A
- AMZE 2021
- Fundamental
- Price
- JAGX $4.06
- AMZE $0.30
- Analyst Decision
- JAGX Strong Buy
- AMZE
- Analyst Count
- JAGX 1
- AMZE 0
- Target Price
- JAGX $60.00
- AMZE N/A
- AVG Volume (30 Days)
- JAGX 108.8K
- AMZE 127.8K
- Earning Date
- JAGX 05-15-2025
- AMZE 05-20-2025
- Dividend Yield
- JAGX N/A
- AMZE N/A
- EPS Growth
- JAGX N/A
- AMZE N/A
- EPS
- JAGX N/A
- AMZE N/A
- Revenue
- JAGX $11,552,000.00
- AMZE $254,711.00
- Revenue This Year
- JAGX $22.41
- AMZE N/A
- Revenue Next Year
- JAGX $30.00
- AMZE N/A
- P/E Ratio
- JAGX N/A
- AMZE N/A
- Revenue Growth
- JAGX 13.93
- AMZE N/A
- 52 Week Low
- JAGX $3.75
- AMZE $0.25
- 52 Week High
- JAGX $110.75
- AMZE $1.25
- Technical
- Relative Strength Index (RSI)
- JAGX 33.50
- AMZE N/A
- Support Level
- JAGX $4.27
- AMZE N/A
- Resistance Level
- JAGX $4.90
- AMZE N/A
- Average True Range (ATR)
- JAGX 0.49
- AMZE 0.00
- MACD
- JAGX -0.04
- AMZE 0.00
- Stochastic Oscillator
- JAGX 9.27
- AMZE 0.00
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.